Russell Investments Group’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-171,479
Closed -$4.71M 3020
2022
Q3
$4.71M Hold
171,479
0.01% 1079
2022
Q2
$3.95M Sell
171,479
-1,083
-0.6% -$25.3K 0.01% 1220
2022
Q1
$3.76M Buy
172,562
+4,872
+3% +$101K 0.01% 1308
2021
Q4
$3.58M Buy
167,690
+1,734
+1% +$36.4K 0.01% 1463
2021
Q3
$3.47M Sell
165,956
-254,558
-61% -$5.55M 0.01% 1470
2021
Q2
$9.69M Buy
420,514
+82,934
+25% +$1.91M 0.02% 956
2021
Q1
$7.46M Sell
337,580
-381,558
-53% -$8.83M 0.01% 1129
2020
Q4
$13.4M Sell
719,138
-20,644
-3% -$339K 0.03% 686
2020
Q3
$10.7M Buy
739,782
+229,790
+45% +$2.92M 0.02% 727
2020
Q2
$5.71M Sell
509,992
-71,001
-12% -$797K 0.01% 1024
2020
Q1
$5.88M Buy
+580,993
New +$8.12M 0.02% 869
2019
Q3
Sell
-415,244
Closed -$6.06M 3124
2019
Q2
$6.06M Buy
+415,244
New +$6.15M 0.01% 1128

Other funds holding CHNG

Russell Investments Group's CHNG Position: Q4 2022 in Review

Russell Investments Group sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 171,479 shares — an estimated $4.71M sold.

Russell Investments Group first reported a position in CHNG in Q2 2019 and held it in 12 quarters. The position peaked at $13.4M in Q4 2020. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Russell Investments Group reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 171,479 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $4.71M.
  • Russell Investments Group first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • Russell Investments Group's Change Healthcare Inc. Common Stock position peaked at $13.4M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.